Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mediwound Ltd Ord Sh (NQ: MDWD ) 14.51 -1.05 (-6.75%) Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 89,051 Open 15.50 Bid (Size) 14.75 (12) Ask (Size) 15.00 (1) Prev. Close 15.56 Today's Range 14.43 - 15.69 52wk Range 7.100 - 19.86 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q1 2024 May 29, 2024 MDWD stock results show that MediWound beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace MediWound Reports First Quarter 2024 Financial Results and Provides Company Update May 29, 2024 From MediWound Ltd. Via GlobeNewswire Performance YTD +28.98% +28.98% 1 Month -12.06% -12.06% 3 Month -3.01% -3.01% 6 Month +21.42% +21.42% 1 Year +35.48% +35.48% More News Read More MediWound to Report First Quarter 2024 Financial Results May 22, 2024 From MediWound Ltd. Via GlobeNewswire MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences April 25, 2024 From MediWound Ltd. Via GlobeNewswire Preview: MediWound's Earnings March 20, 2024 Via Benzinga Recap: MediWound Q3 Earnings November 21, 2023 Via Benzinga Earnings Outlook For MediWound November 20, 2023 Via Benzinga MediWound Ltd. (NASDAQ: MDWD) Sets New 52-Week High in Wednesday Session April 17, 2024 Via Investor Brand Network MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q4 2023 March 21, 2024 Via InvestorPlace MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update March 21, 2024 From MediWound Ltd. Via GlobeNewswire MediWound to Report Fourth Quarter and Full Year 2023 Financial Results March 14, 2024 From MediWound Ltd. Via GlobeNewswire Earnings Scheduled For March 21, 2024 March 21, 2024 Via Benzinga MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study February 12, 2024 From MediWound Ltd. Via GlobeNewswire MediWound to Participate in Two Upcoming Investor Conferences February 05, 2024 From MediWound Ltd. Via GlobeNewswire MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns January 09, 2024 From MediWound Ltd. Via GlobeNewswire Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development December 28, 2023 Via Benzinga MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army December 28, 2023 From MediWound Ltd. Via GlobeNewswire MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads December 21, 2023 From MediWound Ltd. Via GlobeNewswire Earnings Scheduled For November 21, 2023 November 21, 2023 Via Benzinga MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update November 21, 2023 From MediWound Ltd. Via GlobeNewswire MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer November 21, 2023 From MediWound Ltd. Via GlobeNewswire MediWound to Report Third Quarter 2023 Financial Results November 14, 2023 From MediWound Ltd. Via GlobeNewswire MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid® to Treat Pediatric Patients November 13, 2023 From MediWound Ltd. Via GlobeNewswire MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid® Distribution in Europe November 08, 2023 From MediWound Ltd. Via GlobeNewswire MediWound Announces Collaboration with 3M on EscharEx® Phase III Study October 11, 2023 From MediWound Ltd. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
